LEADER 00783nam a2200229 i 4500 001 991000485849707536 008 041013 2002 enka eng 020 $a0297607413 035 $ab13227944-39ule_inst 040 $aDip.to Filosofia$bita 100 1 $aMayr, Ernst$064724 245 10$aWhat evolution is /$cErnst Mayr 260 $aXV, 318 p. :$bill. ;$c24 cm 300 $aLondon :$bWeidenfeld & Nicolson,$c2002 440 0$aScience master 650 4$aEvoluzione 907 $a.b13227944$b21-09-06$c13-10-04 912 $a991000485849707536 945 $aLE005 500 MAY01. 03$g1$i2005000148644$lle005$o-$pE22.83$q-$rl$s- $t0$u0$v0$w0$x0$y.i13894973$z13-10-04 996 $aWhat evolution is$91099646 997 $aUNISALENTO 998 $ale005$b13-10-04$cm$da $e-$feng$genk$h0$i0 LEADER 03088nam 2200553 a 450 001 9910791133703321 005 20200520144314.0 010 $a1-61668-114-4 035 $a(CKB)2560000000008025 035 $a(EBL)3020194 035 $a(SSID)ssj0000336288 035 $a(PQKBManifestationID)12091907 035 $a(PQKBTitleCode)TC0000336288 035 $a(PQKBWorkID)10277942 035 $a(PQKB)11215256 035 $a(MiAaPQ)EBC3020194 035 $a(Au-PeEL)EBL3020194 035 $a(CaPaEBR)ebr10676325 035 $a(OCoLC)529875288 035 $a(EXLCZ)992560000000008025 100 $a20060111d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCOX-2 inhibitor research$b[electronic resource] /$fMaynard J. Howardell, editor 210 $aNew York $cNova Science Publishers$dc2006 215 $a1 online resource (263 p.) 300 $aDescription based upon print version of record. 311 $a1-59454-994-X 320 $aIncludes bibliographical references and index. 327 $aCyclooxygenase-2 inhibitor and gastric cancer / Yumin Li, Raaj K. Praseedom, and Andrew Butler et al. -- Prevention and chemoprevention of gastric cancer : dietary habits, Helicobacter pylori and COX-2 inhibitors / Gerardo Nardone and Alba Rocco -- Cyclooxygenases in cancer / Daniela Fodera ... et al. -- Nephrotoxicity of nonsteroidal anti-inflammatory drugs : focus on selective cyclooxygenase-2 (COX-2) inhibitors / Steven G. Coca and Mark A. Perazella -- Are COX-2 inhibitors active on intracellular oxidative processes? A study on in vitro and cellular models / Ange Mouithys-Mickalad et al. -- Theoretical mechanism studies on dual inhibition of human cyclooxygenase-2 and 5-lipoxygenase by diaryl-pyrrolizine derivatives / R. Pouplana, C. Perez, and J. Ruiz -- 327 $aNSAIDs in animal models of Alzheimer's disease / N.G. Giovannini, C. Scali, and A. Bellucci -- Relevance of COX-2 inhibitors in Alzheimer's disease / Amita Quadros, Laila Abdullah, and Nikunj Patel et al. -- COX.1-COX.2 simultaneous inhibitory mechanism in gastric injury and COX.2-COX.3 in small intestine injury / Laudanno Oscar -- Effects of COX-2 inhibitors on brain diseases / Takako Takemiya -- Cyclooxygenase-2 overexpression and the chemopreventive and therapeutic uses of cyclooxygenase inhibitors in lung cancer / Zhongxing Liao et al. -- Safety monitoring of celecoxib and rofecoxib in the New Zealand intensive medicines monitoring programme / David Coutler et al. 606 $aNonsteroidal anti-inflammatory agents 606 $aArthritis$xChemotherapy 606 $aAnti-inflammatory agents 615 0$aNonsteroidal anti-inflammatory agents. 615 0$aArthritis$xChemotherapy. 615 0$aAnti-inflammatory agents. 676 $a615/.7 701 $aHowardell$b Maynard J$01527208 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910791133703321 996 $aCOX-2 inhibitor research$93769790 997 $aUNINA